Financing
Financing Cash Flow
Regeneron Pharmaceuticals Financing Cash Flow decreased by 2.8% to -$802.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.3%, from -$1.09B to -$802.20M. Over 3 years (FY 2022 to FY 2025), Financing Cash Flow shows a downward trend with a 54.4% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026
How to read this metric
Negative values often indicate a company is paying down debt or returning capital to shareholders, while positive values may indicate external financing.
Detailed definition
The net result of all cash inflows and outflows related to financing activities, including debt issuance, debt repayment...
Peer comparison
Highly dependent on the company's current capital structure and lifecycle stage compared to industry peers.
Metric ID:
net_cash_from_financingHistorical Data
19 periods
| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$118.20M | -$906.60M | $64.70M | -$101.10M | -$725.00M | -$247.60M | -$322.50M | -$614.20M | -$407.30M | -$446.10M | $47.10M | -$478.10M | -$634.00M | -$1.14B | -$1.09B | -$1.13B | -$717.90M | -$780.10M | -$802.20M |
| QoQ Change | — | -667.0% | +107.1% | -256.3% | -617.1% | +65.8% | -30.3% | -90.4% | +33.7% | -9.5% | +110.6% | <-999% | -32.6% | -79.1% | +4.1% | -3.6% | +36.4% | -8.7% | -2.8% |
| YoY Change | — | — | — | +14.5% | — | +72.7% | -598.5% | -507.5% | +43.8% | -80.2% | +114.6% | +22.2% | -55.7% | -154.5% | <-999% | -136.0% | -13.2% | +31.3% | +26.3% |
Range-$1.14B – $64.70M
CAGR+53.0%
Avg YoY Growth-242.2%
Median YoY Growth-13.2%
Current Streak2 quarters decline
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's financing cash flow?
- Regeneron Pharmaceuticals (REGN) reported financing cash flow of -$802.20M in Q1 2026.
- How has Regeneron Pharmaceuticals's financing cash flow changed year-over-year?
- Regeneron Pharmaceuticals's financing cash flow increased by 26.3% year-over-year, from -$1.09B to -$802.20M.
- What is the long-term trend for Regeneron Pharmaceuticals's financing cash flow?
- Over 3 years (2022 to 2025), Regeneron Pharmaceuticals's financing cash flow has grown at a 54.4% compound annual growth rate (CAGR), from -$1.01B to -$3.72B.
- What does financing cash flow mean?
- The net cash flow generated or used by financing activities.